Role of the Autotaxin–lysophosphatidate Axis in Cancer Resistance to Chemotherapy and Radiotherapy

Biochimica et Biophysica Acta - Molecular and Cell Biology of Lipids - Netherlands
doi 10.1016/j.bbalip.2012.08.015
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

The Critical Role and Potential Target of the Autotaxin/Lysophosphatidate Axis in Pancreatic Cancer

Tumor Biology
MedicineCancer Research
2017English

Recent Advances in Targeting the Autotaxin-Lysophosphatidate-Lipid Phosphate Phosphatase Axis in Vivo

Journal of Biomedical Research
BiochemistryMedicineGeneticsMolecular Biology
2016English

The Role of P53 in Cancer Drug Resistance and Targeted Chemotherapy

Oncotarget
Oncology
2016English

Acquired Resistance to Cancer Chemotherapy.

BMJ
1984English

The Role of GLI-SOX2 Signaling Axis for Gemcitabine Resistance in Pancreatic Cancer

Oncogene
Cancer ResearchGeneticsMolecular Biology
2018English

Developments in Neoadjuvant Chemotherapy and Radiotherapy in Rectal Cancer

2012English

Limited-Stage Hodgkin Lymphoma: Optimal Chemotherapy and the Role of Radiotherapy

American Society of Clinical Oncology educational book / ASCO. American Society of Clinical Oncology. Meeting
Medicine
2013English

Common Metabolic Pathways Implicated in Resistance to Chemotherapy Point to a Key Mitochondrial Role in Breast Cancer

Molecular and Cellular Proteomics
BiochemistryMedicineAnalytical ChemistryMolecular Biology
2018English

Untangling the Role of Polycomb Complexes in Chemotherapy Resistance

Cancer Discovery
Oncology
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy